Glück Conviction Score™ ⓘ
SION
Sionna Therapeutics, Inc.
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
33,7
28 neu, 38 erhöht, 719K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 40.05 | -10.3 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 36.98 | -2.9 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 37.87 | EMA50: 39.04 | |
| MACD-Histogramm | Bärisch | 10 % | -0.505 | Bearisch | |
| RSI(14) | Neutral | 10 % | 42.7 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 29.6 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 16.4 | +DI: 19.1 / −DI: 26.2 | |
| Z-Score(60) | Neutral | 5 % | -1.16 | In Range | |
| 52W-Position | Neutral | 5 % | 68.8 % | Hoch 45.95 / Tief 13.85 | |
| Bollinger(20,2σ) | Neutral | 5 % | 29.2 % | Upper 45.03 / Mid 38.59 / Lower 32.16 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0013 | R²=0.00 / annualisiert +0.8 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -101 | 44,49 | -4.493,49 | -0,4% | |
| 2026-05-27 | Thompson Peter A. | Director | Open Market Sale | -101 | 44,49 | -4.493,49 | -0,4% | |
| 2026-05-11 | Thompson Peter A. | Director | Open Market Sale | -184.639 | 46,22 | -8.534.014,58 | -837,7% | |
| 2026-05-11 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -184.639 | 46,22 | -8.534.014,58 | -837,7% | |
| 2026-05-08 | Thompson Peter A. | Director | Open Market Sale | -59.767 | 44,58 | -2.664.412,86 | -261,5% | |
| 2026-05-08 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -59.767 | 44,58 | -2.664.412,86 | -261,5% | |
| 2026-05-07 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -48.546 | 44,61 | -2.165.637,06 | -212,6% | |
| 2026-05-07 | Thompson Peter A. | Director | Open Market Sale | -48.546 | 44,61 | -2.165.637,06 | -212,6% | |
| 2026-04-18 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -2.948 | 44,52 | -131.244,96 | -12,9% | |
| 2026-04-18 | Thompson Peter A. | Director | Open Market Sale | -2.948 | 44,52 | -131.244,96 | -12,9% | |
| 2026-04-17 | Thompson Peter A. | Director | Open Market Sale | -52.397 | 44,68 | -2.341.097,96 | -229,8% | |
| 2026-04-17 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -52.397 | 44,68 | -2.341.097,96 | -229,8% | |
| 2026-04-16 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -226.906 | 45,34 | -10.287.918,04 | -1009,8% | |
| 2026-04-16 | Thompson Peter A. | Director | Open Market Sale | -226.906 | 45,34 | -10.287.918,04 | -1009,8% | |
| 2026-04-15 | Thompson Peter A. | Director | Open Market Sale | -235.863 | 44,64 | -10.528.924,32 | -1033,5% | |
| 2026-04-15 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -235.863 | 44,64 | -10.528.924,32 | -1033,5% | |
| 2026-04-14 | Thompson Peter A. | Director | Open Market Sale | -47.814 | 44,51 | -2.128.201,14 | -208,9% | |
| 2026-04-14 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -47.814 | 44,51 | -2.128.201,14 | -208,9% | |
| 2026-03-05 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 33,86 | -347.018,88 | -34,1% | |
| 2026-02-03 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -29.063 | 44,58 | -1.295.628,54 | -127,2% | |
| 2026-02-03 | Thompson Peter A. | Director | Open Market Sale | -29.063 | 44,58 | -1.295.628,54 | -127,2% | |
| 2026-02-02 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -1.890 | 44,57 | -84.237,30 | -8,3% | |
| 2026-02-02 | Thompson Peter A. | Director | Open Market Sale | -1.890 | 44,57 | -84.237,30 | -8,3% | |
| 2026-01-22 | TPG GP A, LLC | 10% Owner | Open Market Sale | -250.000 | 40,00 | -10.000.000,00 | -981,6% | |
| 2025-12-24 | Thompson Peter A. | Director | Open Market Sale | -33.356 | 44,55 | -1.486.009,80 | -145,9% | |
| 2025-12-24 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -33.356 | 44,55 | -1.486.009,80 | -145,9% | |
| 2025-12-19 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -875 | 44,49 | -38.928,75 | -3,8% | |
| 2025-12-19 | Thompson Peter A. | Director | Open Market Sale | -875 | 44,49 | -38.928,75 | -3,8% | |
| 2025-12-18 | Thompson Peter A. | Director | Open Market Sale | -100 | 44,49 | -4.449,00 | -0,4% | |
| 2025-12-18 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -100 | 44,49 | -4.449,00 | -0,4% | |
| 2025-12-17 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -900 | 44,50 | -40.050,00 | -3,9% | |
| 2025-12-17 | Thompson Peter A. | Director | Open Market Sale | -900 | 44,50 | -40.050,00 | -3,9% | |
| 2025-12-05 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 40,52 | -415.330,00 | -40,8% | |
| 2025-11-26 | Thompson Peter A. | Director | Open Market Sale | -1.600 | 44,49 | -71.184,00 | -7,0% | |
| 2025-11-26 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -1.600 | 44,49 | -71.184,00 | -7,0% | |
| 2025-11-25 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -11.890 | 44,60 | -530.294,00 | -52,1% | |
| 2025-11-25 | Thompson Peter A. | Director | Open Market Sale | -11.890 | 44,60 | -530.294,00 | -52,1% | |
| 2025-11-24 | Thompson Peter A. | Director | Open Market Sale | -94.583 | 44,54 | -4.212.726,82 | -413,5% | |
| 2025-11-24 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -94.583 | 44,54 | -4.212.726,82 | -413,5% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -6.440 | 39,50 | -254.380,00 | -25,0% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9.924 | 39,50 | -391.998,00 | -38,5% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -7.609 | 39,50 | -300.555,50 | -29,5% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.210 | 39,50 | -47.795,00 | -4,7% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -150 | 39,89 | -5.983,50 | -0,6% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.235 | 39,89 | -49.264,15 | -4,8% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -947 | 39,89 | -37.775,83 | -3,7% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -801 | 39,89 | -31.951,89 | -3,1% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -788 | 40,50 | -31.914,00 | -3,1% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -604 | 40,50 | -24.462,00 | -2,4% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -512 | 40,50 | -20.736,00 | -2,0% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -96 | 40,50 | -3.888,00 | -0,4% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.276 | 40,01 | -91.062,76 | -8,9% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -18.684 | 40,01 | -747.546,84 | -73,4% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -14.325 | 40,01 | -573.143,25 | -56,3% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -12.126 | 40,01 | -485.161,26 | -47,6% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -12 | 40,61 | -487,32 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9 | 40,61 | -365,49 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -8 | 40,61 | -324,88 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2 | 40,61 | -81,22 | 0,0% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -332 | 39,57 | -13.137,24 | -1,3% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.728 | 39,57 | -107.946,96 | -10,6% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.092 | 39,57 | -82.780,44 | -8,1% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.770 | 39,57 | -70.038,90 | -6,9% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -11.626 | 40,20 | -467.365,20 | -45,9% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -10.707 | 41,05 | -439.522,35 | -43,1% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9.063 | 41,05 | -372.036,15 | -36,5% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.182 | 40,20 | -87.716,40 | -8,6% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -53 | 42,10 | -2.231,30 | -0,2% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.701 | 41,05 | -69.826,05 | -6,9% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -433 | 42,10 | -18.229,30 | -1,8% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -280 | 42,10 | -11.788,00 | -1,2% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -331 | 42,10 | -13.935,10 | -1,4% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -17.913 | 40,20 | -720.102,60 | -70,7% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -13.964 | 41,05 | -573.222,20 | -56,3% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -13.734 | 40,20 | -552.106,80 | -54,2% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -17.118 | 39,58 | -677.530,44 | -66,5% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -3.624 | 39,58 | -143.437,92 | -14,1% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -10.476 | 39,58 | -414.640,08 | -40,7% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -31.392 | 39,58 | -1.242.495,36 | -122,0% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -107.941 | 39,50 | -4.263.669,50 | -418,5% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -66.672 | 39,50 | -2.633.544,00 | -258,5% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -14.116 | 39,50 | -557.582,00 | -54,7% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -122.271 | 39,50 | -4.829.704,50 | -474,1% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -13.324 | 34,44 | -458.878,56 | -45,0% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -25.327 | 35,69 | -903.920,63 | -88,7% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -22.339 | 32,69 | -730.261,91 | -71,7% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -19.948 | 33,87 | -675.638,76 | -66,3% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -5.763 | 34,91 | -201.186,33 | -19,7% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -5.316 | 35,69 | -189.728,04 | -18,6% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -4.688 | 32,69 | -153.250,72 | -15,0% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -4.187 | 33,87 | -141.813,69 | -13,9% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -1.210 | 34,91 | -42.241,10 | -4,1% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -17 | 36,42 | -619,14 | -0,1% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -83 | 36,42 | -3.022,86 | -0,3% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -33.532 | 37,31 | -1.251.078,92 | -122,8% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -30.049 | 35,63 | -1.070.645,87 | -105,1% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -22.895 | 36,60 | -837.957,00 | -82,3% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -5.412 | 32,33 | -174.969,96 | -17,2% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -25.788 | 32,33 | -833.726,04 | -81,8% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -20.485 | 31,79 | -651.218,15 | -63,9% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -4.300 | 31,79 | -136.697,00 | -13,4% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -248 | 33,47 | -8.300,56 | -0,8% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -28.821 | 32,10 | -925.154,10 | -90,8% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -21.451 | 32,71 | -701.662,21 | -68,9% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -6.049 | 32,10 | -194.172,90 | -19,1% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -4.503 | 32,71 | -147.293,13 | -14,5% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -52 | 33,47 | -1.740,44 | -0,2% | |
| 2025-10-16 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -10.225 | 31,46 | -321.690,77 | -31,6% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -73.296 | 32,84 | -2.407.040,64 | -236,3% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -45.117 | 31,69 | -1.429.757,73 | -140,3% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -15.384 | 32,84 | -505.210,56 | -49,6% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -12.888 | 33,38 | -430.201,44 | -42,2% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -9.470 | 31,69 | -300.104,30 | -29,5% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -8.596 | 30,15 | -259.169,40 | -25,4% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -2.705 | 33,38 | -90.292,90 | -8,9% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -1.804 | 30,15 | -54.390,60 | -5,3% | |
| 2025-10-16 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -200 | 34,00 | -6.800,00 | -0,7% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -30.032 | 31,12 | -934.595,84 | -91,7% | |
| 2025-10-15 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -14.775 | 31,11 | -459.662,07 | -45,1% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -65.726 | 30,37 | -1.996.098,62 | -195,9% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -13.795 | 30,37 | -418.954,15 | -41,1% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -6.303 | 31,12 | -196.149,36 | -19,3% | |
| 2025-10-14 | Booth Bruce | Director | Open Market Sale | -105 | 29,95 | -3.144,75 | -0,3% | |
| 2025-10-14 | Booth Bruce | Director | Open Market Sale | -501 | 29,95 | -15.004,95 | -1,5% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -4.082 | 31,03 | -126.664,46 | -12,4% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -44.048 | 30,32 | -1.335.535,36 | -131,1% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -9.245 | 30,32 | -280.308,40 | -27,5% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -857 | 31,03 | -26.592,71 | -2,6% | |
| 2025-10-10 | Booth Bruce | Director | Open Market Sale | -16.727 | 29,98 | -501.475,46 | -49,2% | |
| 2025-10-10 | Booth Bruce | Director | Open Market Sale | -3.511 | 29,98 | -105.259,78 | -10,3% | |
| 2025-10-06 | Booth Bruce | Director | Open Market Sale | -9.753 | 29,95 | -292.102,35 | -28,7% | |
| 2025-10-06 | Booth Bruce | Director | Open Market Sale | -2.047 | 29,95 | -61.307,65 | -6,0% | |
| 2025-10-03 | Booth Bruce | Director | Open Market Sale | -31.198 | 30,00 | -935.940,00 | -91,9% | |
| 2025-10-03 | Booth Bruce | Director | Open Market Sale | -6.548 | 30,00 | -196.440,00 | -19,3% | |
| 2025-10-01 | Booth Bruce | Director | Open Market Sale | -165 | 29,95 | -4.941,75 | -0,5% | |
| 2025-10-01 | Booth Bruce | Director | Open Market Sale | -35 | 29,95 | -1.048,25 | -0,1% | |
| 2025-09-30 | Booth Bruce | Director | Open Market Sale | -2.149 | 30,06 | -64.598,94 | -6,3% | |
| 2025-09-30 | Booth Bruce | Director | Open Market Sale | -10.239 | 30,06 | -307.784,34 | -30,2% | |
| 2025-09-29 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -7.793 | 29,70 | -231.451,32 | -22,7% | |
| 2025-09-29 | Booth Bruce | Director | Open Market Sale | -54.637 | 30,09 | -1.644.027,33 | -161,4% | |
| 2025-09-29 | Booth Bruce | Director | Open Market Sale | -11.468 | 30,09 | -345.072,12 | -33,9% | |
| 2025-09-26 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -17.207 | 28,85 | -496.346,24 | -48,7% | |
| 2025-09-04 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 23,12 | -236.980,00 | -23,3% | |
| 2025-09-02 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -8.836 | 25,08 | -221.606,88 | -21,8% | |
| 2025-08-29 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -748 | 25,18 | -18.834,64 | -1,8% | |
| 2025-08-28 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -16.098 | 25,97 | -418.065,06 | -41,0% | |
| 2025-08-27 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -3.618 | 25,10 | -90.811,80 | -8,9% | |
| 2025-08-27 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -7.426 | 25,01 | -185.713,86 | -18,2% | |
| 2025-08-26 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -17.574 | 24,96 | -438.647,04 | -43,1% | |
| 2025-08-26 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -3.700 | 25,13 | -92.981,00 | -9,1% | |
| 2025-08-20 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -25.000 | 22,75 | -568.750,00 | -55,8% | |
| 2025-08-20 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -17.500 | 22,69 | -397.075,00 | -39,0% | |
| 2025-08-19 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -34.500 | 21,08 | -727.260,00 | -71,4% | |
| 2025-06-27 | TPG GP A, LLC | 10% Owner | Open Market Purchase | 60.000 | 15,84 | 950.400,00 | +93,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.905.045 | 9.905.045 | 0 | 397.093.254 | Unverändert | 0,0% | |
| TPG GP A, LLC | 6.494.962 | 6.744.962 | -250.000 | 260.383.027 | Reduziert | -3,7% | |
| ORBIMED ADVISORS LLC | 3.530.702 | 3.561.655 | -30.953 | 141.545.843 | Reduziert | -0,9% | |
| VIKING GLOBAL INVESTORS LP | 3.195.181 | 3.195.181 | 0 | 128.094.806 | Unverändert | 0,0% | |
| Atlas Venture Life Science Advisors, LLC | 2.995.602 | 2.995.602 | 0 | 120.093.684 | Unverändert | 0,0% | |
| Enavate Sciences GP, LLC | 2.478.030 | 2.478.030 | 0 | 99.344.223 | Unverändert | 0,0% | |
| JENNISON ASSOCIATES LLC | 1.451.220 | 1.115.278 | 335.942 | 58.179.411 | Aufgestockt | +30,1% | |
| BlackRock, Inc. | 1.295.867 | 1.291.599 | 4.268 | 51.951.309 | Aufgestockt | +0,3% | |
| JPMORGAN CHASE & CO | 1.231.819 | 0 | 1.231.819 | 50.677.035 | Neu | +100,0% | |
| VANGUARD GROUP INC | 1.184.951 | 0 | 1.184.951 | 48.748.883 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.166.931 | 1.087.325 | 79.606 | 46.782.264 | Aufgestockt | +7,3% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.029.497 | 0 | 1.029.497 | 41.272.535 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 970.590 | 970.590 | 0 | 38.910.953 | Unverändert | 0,0% | |
| STATE STREET CORP | 756.227 | 693.395 | 62.832 | 30.317.140 | Aufgestockt | +9,1% | |
| PERCEPTIVE ADVISORS LLC | 658.439 | 1.179.098 | -520.659 | 26.396.820 | Reduziert | -44,2% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 645.530 | 639.045 | 6.485 | 25.875.888 | Aufgestockt | +1,0% | |
| Aberdeen Group plc | 564.175 | 839.960 | -275.785 | 22.617.776 | Reduziert | -32,8% | |
| BAKER BROS. ADVISORS LP | 400.000 | 400.000 | 0 | 16.036.000 | Unverändert | 0,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 389.872 | 380.042 | 9.830 | 15.633.527 | Aufgestockt | +2,6% | |
| Siren, L.L.C. | 300.000 | 300.000 | 0 | 12.027.000 | Unverändert | 0,0% | |
| Sio Capital Management, LLC | 294.340 | 0 | 294.340 | 11.800.091 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 293.500 | 268.500 | 25.000 | 11.766.415 | Aufgestockt | +9,3% | |
| GOLDMAN SACHS GROUP INC | 263.174 | 36.269 | 226.905 | 10.550.646 | Aufgestockt | +625,6% | |
| Ensign Peak Advisors, Inc | 255.636 | 79.862 | 175.774 | 10.248.447 | Aufgestockt | +220,1% | |
| Candriam S.C.A. | 236.813 | 0 | 236.813 | 9.493.833 | Neu | +100,0% | |
| Kalehua Capital Management LLC | 197.072 | 197.072 | 0 | 7.900.616 | Unverändert | 0,0% | |
| FRANKLIN RESOURCES INC | 175.483 | 175.483 | 0 | 7.035.113 | Unverändert | 0,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 150.000 | 0 | 150.000 | 6.013.500 | Neu | +100,0% | |
| UBS Group AG | 147.641 | 89.177 | 58.464 | 5.918.928 | Aufgestockt | +65,6% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 141.024 | 180.593 | -39.569 | 5.653.652 | Reduziert | -21,9% | |
| MILLENNIUM MANAGEMENT LLC | 140.641 | 80.546 | 60.095 | 5.638.298 | Aufgestockt | +74,6% | |
| Point72 Asset Management, L.P. | 136.549 | 0 | 136.549 | 5.474.249 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 136.222 | 136.222 | 0 | 5.461.140 | Unverändert | 0,0% | |
| GordonMD Global Investments LP | 136.000 | 0 | 136.000 | 5.452.240 | Neu | +100,0% | |
| MORGAN STANLEY | 133.023 | 49.876 | 83.147 | 5.332.893 | Aufgestockt | +166,7% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 120.253 | 123.686 | -3.433 | 4.820.943 | Reduziert | -2,8% | |
| NORTHERN TRUST CORP | 116.776 | 112.116 | 4.660 | 4.681.551 | Aufgestockt | +4,2% | |
| Rock Springs Capital Management LP | 99.429 | 99.429 | 0 | 3.986.109 | Unverändert | 0,0% | |
| Rhenman & Partners Asset Management AB | 87.500 | 0 | 87.500 | 3.507.875 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 82.996 | 113.352 | -30.356 | 3.327.310 | Reduziert | -26,8% | |
| AMERIPRISE FINANCIAL INC | 81.974 | 101.643 | -19.669 | 3.286.338 | Reduziert | -19,4% | |
| FMR LLC | 81.395 | 384 | 81.011 | 3.263.126 | Aufgestockt | +21096,6% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 76.633 | 83.850 | -7.217 | 3.072.217 | Reduziert | -8,6% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 64.458 | 69.424 | -4.966 | 2.584.121 | Reduziert | -7,2% | |
| BANK OF AMERICA CORP /DE/ | 50.870 | 43.567 | 7.303 | 2.039.378 | Aufgestockt | +16,8% | |
| Integral Health Asset Management, LLC | 50.000 | 0 | 50.000 | 2.004.500 | Neu | +100,0% | |
| SEVEN GRAND MANAGERS, LLC | 50.000 | 50.000 | 0 | 2.004.500 | Unverändert | 0,0% | |
| Ishara Investments LP | 49.200 | 0 | 49.200 | 1.972.428 | Neu | +100,0% | |
| Russell Investments Group, Ltd. | 48.419 | 21.941 | 26.478 | 1.941.133 | Aufgestockt | +120,7% | |
| WELLINGTON MANAGEMENT GROUP LLP | 46.079 | 38.347 | 7.732 | 1.847.306 | Aufgestockt | +20,2% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.905.045 | 9.905.045 | 0,0% | 397.093.254 | 22,46 |
| TPG GP A, LLC | 6.494.962 | 6.744.962 | -3,7% | 260.383.027 | 14,73 |
| ORBIMED ADVISORS LLC | 3.530.702 | 3.561.655 | -0,9% | 141.545.843 | 8,01 |
| VIKING GLOBAL INVESTORS LP | 3.195.181 | 3.195.181 | 0,0% | 128.094.806 | 7,25 |
| Atlas Venture Life Science Advisors, LLC | 2.995.602 | 2.995.602 | 0,0% | 120.093.684 | 6,79 |
| Enavate Sciences GP, LLC | 2.478.030 | 2.478.030 | 0,0% | 99.344.223 | 5,62 |
| JENNISON ASSOCIATES LLC | 1.451.220 | 1.115.278 | +30,1% | 58.179.411 | 3,29 |
| JPMORGAN CHASE & CO | 1.465.014 | 1.231.819 | +18,9% | 53.707.413 | 3,04 |
| BlackRock, Inc. | 1.295.867 | 1.291.599 | +0,3% | 51.951.309 | 2,94 |
| CITADEL ADVISORS LLC | 1.166.931 | 1.087.325 | +7,3% | 46.782.264 | 2,65 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.029.497 | 0 | +100,0% | 41.272.535 | 2,33 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 970.590 | 970.590 | 0,0% | 38.910.953 | 2,20 |
| STATE STREET CORP | 756.227 | 693.395 | +9,1% | 30.317.140 | 1,72 |
| PERCEPTIVE ADVISORS LLC | 658.439 | 1.179.098 | -44,2% | 26.396.820 | 1,49 |
| EVENTIDE ASSET MANAGEMENT, LLC | 645.530 | 639.045 | +1,0% | 25.875.888 | 1,46 |
| Aberdeen Group plc | 564.175 | 839.960 | -32,8% | 22.617.776 | 1,28 |
| BAKER BROS. ADVISORS LP | 400.000 | 400.000 | 0,0% | 16.036.000 | 0,91 |
| GEODE CAPITAL MANAGEMENT, LLC | 389.872 | 380.042 | +2,6% | 15.633.527 | 0,88 |
| Siren, L.L.C. | 300.000 | 300.000 | 0,0% | 12.027.000 | 0,68 |
| Sio Capital Management, LLC | 294.340 | 0 | +100,0% | 11.800.091 | 0,67 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 118 | 47,2 | 1.856 |
| 31.12.2025 | ✓ | 97 | 43,9 | 1.770 |
| 30.09.2025 | ✓ | 77 | 44,8 | 1.300 |
| 30.06.2025 | ✓ | 64 | 43,5 | 738 |
| 31.03.2025 | ✓ | 47 | 43,3 | 443 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 639.045 | 26.290.311 |
| Kalehua Capital Management LLC | 197.072 | 8.107.542 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 180.593 | 7.429.596 |
| Invesco Ltd. | 111.162 | 4.573.206 |
| Ensign Peak Advisors, Inc | 79.862 | 3.285.523 |
| SEVEN GRAND MANAGERS, LLC | 50.000 | 2.057.000 |
| ALPS ADVISORS INC | 36.648 | 1.507.699 |
| Rafferty Asset Management, LLC | 24.690 | 1.015.747 |
| ALLIANCEBERNSTEIN L.P. | 15.620 | 642.607 |
| PROFUND ADVISORS LLC | 9.213 | 379.023 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 1.087.325 | 1.051.402 | +2926.8 % | 44.732.551 |
| STATE STREET CORP | 693.395 | 453.196 | +188.7 % | 28.526.270 |
| BlackRock, Inc. | 1.291.599 | 446.994 | +52.9 % | 53.136.382 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 831.373 | 193.613 | +30.4 % | 34.203 |
| JENNISON ASSOCIATES LLC | 1.115.278 | 117.903 | +11.8 % | 45.882.536 |
| GEODE CAPITAL MANAGEMENT, LLC | 380.042 | 63.478 | +20.1 % | 15.638.406 |
| UBS Group AG | 89.177 | 42.511 | +91.1 % | 3.668.741 |
| VANGUARD GROUP INC | 1.184.951 | 41.797 | +3.7 % | 48.748.883 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 69.424 | 37.344 | +116.4 % | 2.872.135 |
| BANK OF AMERICA CORP /DE/ | 43.567 | 37.026 | +566.1 % | 1.792.346 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 1.231.819 | -746.807 | -37.7 % | 50.677.035 |
| Atlas Venture Life Science Advisors, LLC | 2.995.602 | -619.925 | -17.1 % | 123.239.066 |
| RA CAPITAL MANAGEMENT, L.P. | 9.905.045 | -540.277 | -5.2 % | 407.493.551 |
| Soleus Capital Management, L.P. | 268.500 | -145.000 | -35.1 % | 11.046.090 |
| ORBIMED ADVISORS LLC | 3.561.655 | -143.304 | -3.9 % | 146.526.487 |
| MILLENNIUM MANAGEMENT LLC | 80.546 | -133.539 | -62.4 % | 3.313.662 |
| Aberdeen Group plc | 839.960 | -110.587 | -11.6 % | 34.555.954 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 41.460 | -67.341 | -61.9 % | 1.705.664 |
| FRANKLIN RESOURCES INC | 175.483 | -66.664 | -27.5 % | 7.219.371 |
| AMERIPRISE FINANCIAL INC | 101.643 | -51.508 | -33.6 % | 4.181.593 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | HALVORSEN OLE ANDREAS | Passiv (13G/A) | 7,10 % | 3.195.181 | +0,40 pp | |
| 15.05.2026 | Viking Global Opportunities Portfolio GP LLC | Passiv (13G/A) | 4,50 % | 2.039.801 | +0,20 pp | |
| 15.05.2026 | Viking Global Opportunities Parent GP LLC | Passiv (13G/A) | 7,10 % | 3.195.181 | +0,40 pp | |
| 15.05.2026 | Viking Global Opportunities Illiquid Investments Sub-Master LP | Passiv (13G/A) | 4,50 % | 2.039.801 | +0,20 pp | |
| 15.05.2026 | Viking Global Opportunities GP LLC | Passiv (13G/A) | 4,50 % | 2.039.801 | +0,20 pp | |
| 15.05.2026 | Viking Global Opportunities Drawdown Portfolio GP LLC | Passiv (13G/A) | 2,60 % | 1.155.380 | +0,20 pp | |
| 15.05.2026 | Viking Global Opportunities Drawdown GP LLC | Passiv (13G/A) | 2,60 % | 1.155.380 | +0,20 pp | |
| 15.05.2026 | Viking Global Opportunities Drawdown (Aggregator) LP | Passiv (13G/A) | 2,60 % | 1.155.380 | +0,20 pp | |
| 15.05.2026 | VIKING GLOBAL INVESTORS LP | Passiv (13G/A) | 7,10 % | 3.195.181 | +0,40 pp | |
| 15.05.2026 | Shabet Rose Sharon | Passiv (13G/A) | 7,10 % | 3.195.181 | +0,40 pp | |
| 12.05.2026 | Q Healthcare Holding LLC | Passiv (13G/A) | 4,50 % | 2.020.258 | -0,50 pp | |
| 12.05.2026 | Qatar Investment Authority | Passiv (13G/A) | 4,50 % | 2.020.258 | -0,50 pp | |
| 21.04.2026 | OrbiMed Capital GP VIII LLC | Aktivist (13D/A) | 6,60 % | 2.967.722 | -1,80 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … |
| 21.04.2026 | ORBIMED ADVISORS LLC | Aktivist (13D/A) | 6,60 % | 2.967.722 | -1,80 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … |
| 07.11.2025 | RA Capital Nexus Fund III, L.P. | Aktivist (13D/A) | 5,00 % | 2.240.708 | -0,30 pp | |
| 07.11.2025 | Rajeev Shah | Aktivist (13D/A) | 22,60 % | 10.071.712 | -1,10 pp | |
| 07.11.2025 | RA Capital Healthcare Fund, L.P. | Aktivist (13D/A) | 15,50 % | 6.905.625 | -0,20 pp | |
| 07.11.2025 | Peter Kolchinsky | Aktivist (13D/A) | 22,60 % | 10.071.712 | -1,10 pp | |
| 07.11.2025 | RA Capital Management, L.P. | Aktivist (13D/A) | 22,60 % | 10.071.712 | -1,10 pp | |
| 31.10.2025 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 4,40 % | 1.980.626 | -0,60 pp | |
| 20.10.2025 | Atlas Venture Fund XI, L.P. | Aktivist (13D/A) | 5,40 % | 2.382.495 | -1,10 pp | |
| 20.10.2025 | Atlas Venture Associates XI, LLC | Aktivist (13D/A) | 5,40 % | 2.382.495 | -1,10 pp | |
| 20.10.2025 | Atlas Venture Associates XI, L.P. | Aktivist (13D/A) | 5,40 % | 2.382.495 | -1,10 pp | |
| 20.10.2025 | Atlas Venture Associates Opportunity II, LLC | Aktivist (13D/A) | 1,60 % | 701.985 | -0,20 pp | |
| 20.10.2025 | Atlas Venture Associates Opportunity II, LP | Aktivist (13D/A) | 1,60 % | 701.985 | -0,20 pp | |
| 20.10.2025 | Atlas Venture Opportunity Fund II, L.P. | Aktivist (13D/A) | 1,60 % | 701.985 | -0,20 pp | |
| 30.07.2025 | JPMORGAN CHASE & CO. | Passiv (13G) | 5,00 % | 2.221.188 | Neu | |
| 16.06.2025 | Qatar Investment Authority | Passiv (13G) | 5,00 % | 2.209.775 | Neu | |
| 16.06.2025 | Q Healthcare Holding LLC | Passiv (13G) | 5,00 % | 2.209.775 | Neu | |
| 18.02.2025 | Jon Winkelried | Aktivist (13D) | 15,20 % | 6.684.962 | Neu | The information set forth in or incorporated by reference in Items 2, 3, 5 and 6 of this… |
| 18.02.2025 | James G. Coulter | Aktivist (13D) | 15,20 % | 6.684.962 | Neu | The information set forth in or incorporated by reference in Items 2, 3, 5 and 6 of this… |
| 18.02.2025 | TPG GP A, LLC | Aktivist (13D) | 15,20 % | 6.684.962 | Neu | The information set forth in or incorporated by reference in Items 2, 3, 5 and 6 of this… |
| 18.02.2025 | Atlas Venture Associates XI, L.P. | Aktivist (13D) | 6,50 % | 2.886.293 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | Atlas Venture Associates Opportunity II, LP | Aktivist (13D) | 1,80 % | 807.727 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | Atlas Venture Associates Opportunity II, LLC | Aktivist (13D) | 1,80 % | 807.727 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | Atlas Venture Associates XI, LLC | Aktivist (13D) | 6,50 % | 2.886.293 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | Atlas Venture Opportunity Fund II, L.P. | Aktivist (13D) | 1,80 % | 807.727 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | Atlas Venture Fund XI, L.P. | Aktivist (13D) | 6,50 % | 2.886.293 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… |
| 18.02.2025 | RA Capital Nexus Fund III, L.P. | Aktivist (13D) | 5,30 % | 2.324.498 | Neu | The Reporting Persons acquired the Common Stock reported herein for investment purposes … |
| 18.02.2025 | RA Capital Management, L.P. | Aktivist (13D) | 23,70 % | 10.445.322 | Neu | The Reporting Persons acquired the Common Stock reported herein for investment purposes … |
Stammdaten
Sionna Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen. Das Unternehmen stellt Therapiekonzepte für Mukoviszidose-Patienten bereit, indem es Arzneimittel entwickelt, die die Funktion des Cystic-Fibrosis-Transmembrane-Conductance-Regulators normalisieren.
Unternehmen & Branche
| Name | Sionna Therapeutics, Inc. |
|---|---|
| Ticker | SION |
| CIK | 0002036042 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 829401108 |
|---|---|
| ISIN | US8294011080 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,61 Mrd. USD |
Bewertung
| KBV (P/B) | 5,25 |
|---|---|
| FCF-Rendite | -4,1 % |
Qualität & Bilanz
| ROIC | -23,9 % |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2024. Kennzahlen erklärt →
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -26.779.000 | -0,60 | 305.039.000 | 288.208.000 | |
| 2025-12-31 | 10-K | -75.268.000 | -1,88 | 325.953.000 | 306.833.000 | |
| 2025-09-30 | 10-Q | -20.278.000 | -0,46 | 339.270.000 | 321.668.000 | |
| 2025-06-30 | 10-Q | -18.068.000 | -410,00 | 352.048.000 | 336.429.000 | |
| 2025-03-31 | 10-Q | -16.482.000 | -620,00 | 369.674.000 | 351.769.000 | |
| 2024-12-31 | 10-K | -61.688.000 | -15,99 | 185.752.000 | -163.713.000 | |
| 2024-09-30 | 10-Q | -25.441.000 | -5,67 | -148.549.000 | ||
| 2024-06-30 | 10-Q | -8.552.000 | -###,## | -133.774.000 | ||
| 2024-03-31 | 10-Q | -11.847.000 | -###,## | -126.083.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 12.05.2026 | – | -0,60 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -0,46 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | – | -410,00 |
| Q1 2025 | 31.03.2025 | 12.05.2026 | – | -0,62 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | – | -5,67 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | – | -2.710,00 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | – | -3.840,00 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 12.05.2026 | 10-Q | – | – | SEC » |
| 02.03.2026 | 10-K | 31.12.2025 | 61 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 20.03.2025 | 10-K | 31.12.2024 | 79 Tage | SEC » |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 174 | 40,94 | 7.124 |
| 2026-05-12 | 1 | 45,95 | 46 |
| 2026-05-08 | 3.243 | 43,31 | 140.454 |
| 2026-05-07 | 198 | 43,29 | 8.571 |
| 2026-05-04 | 1.980 | 39,15 | 77.517 |
| 2026-05-01 | 66 | 38,70 | 2.554 |
| 2026-04-29 | 615 | 39,59 | 24.348 |
| 2026-04-28 | 1.307 | 39,21 | 51.247 |
| 2026-04-27 | 30 | 38,11 | 1.143 |
| 2026-04-22 | 6 | 41,79 | 251 |
| 2026-04-20 | 460 | 43,54 | 20.028 |
| 2026-04-17 | 721 | 45,24 | 32.618 |
| 2026-04-16 | 6.569 | 45,09 | 296.196 |
| 2026-04-14 | 397 | 41,77 | 16.583 |
| 2026-04-13 | 2.168 | 37,89 | 82.146 |
| 2026-04-10 | 10.848 | 38,89 | 421.879 |
| 2026-04-07 | 11 | 37,38 | 411 |
| 2026-04-06 | 15.308 | 40,49 | 619.821 |
| 2026-04-02 | 800 | 41,30 | 33.040 |
| 2026-04-01 | 22.220 | 40,09 | 890.800 |
| 2026-03-31 | 1 | 36,66 | 37 |
| 2026-03-26 | 30 | 37,08 | 1.112 |
| 2026-03-24 | 3.213 | 36,43 | 117.050 |
| 2026-03-19 | 937 | 34,40 | 32.233 |
| 2026-03-16 | 3.940 | 37,32 | 147.041 |
| 2026-03-13 | 1 | 36,68 | 37 |
| 2026-03-11 | 104 | 38,08 | 3.960 |
| 2026-03-09 | 285 | 35,93 | 10.240 |
| 2026-03-05 | 1 | 34,57 | 35 |
| 2026-03-03 | 398 | 33,92 | 13.500 |
| 2026-02-17 | 461 | 37,52 | 17.297 |
| 2026-02-13 | 1.377 | 37,64 | 51.830 |
| 2026-02-11 | 20.054 | 38,02 | 762.453 |
| 2026-02-09 | 7.157 | 36,11 | 258.439 |
| 2026-02-05 | 205 | 41,32 | 8.471 |
| 2026-02-04 | 55 | 44,48 | 2.446 |
| 2026-02-02 | 295 | 42,26 | 12.467 |
| 2026-01-30 | 810 | 42,44 | 34.376 |
| 2026-01-27 | 81 | 42,60 | 3.451 |
| 2026-01-26 | 360 | 42,38 | 15.257 |
| 2026-01-21 | 514 | 40,01 | 20.565 |
| 2026-01-20 | 1.578 | 39,11 | 61.716 |
| 2026-01-16 | 153 | 38,85 | 5.944 |
| 2026-01-15 | 5.185 | 41,18 | 213.518 |
| 2026-01-12 | 9.673 | 39,25 | 379.665 |
| 2026-01-07 | 355 | 37,22 | 13.213 |
| 2026-01-05 | 314 | 39,21 | 12.312 |
| 2026-01-02 | 131 | 41,14 | 5.389 |
| 2025-12-30 | 21 | 42,81 | 899 |
| 2025-12-23 | 506 | 42,42 | 21.465 |
| 2025-12-22 | 4.660 | 42,37 | 197.444 |
| 2025-12-15 | 260 | 42,77 | 11.120 |